Table 1.
Staging | Urine volume | Diagnostic criteria | ||
---|---|---|---|---|
RIFLE (2002) | AKIN (2005) | KIDGO (2012) | ||
1 issue | Urine output <0.5 ml/kg/h > 6 h |
Risk: sCr elevated > 1.5 times or GFR decline > 25% |
sCr elevated ≥ 26.4 μmol/L or elevated > 1.5–2.0 times the baseline value |
sCr elevated ≥ 26.5 μmol/L (0.3 mg/dl) or elevated > 1.5–1.9 times the baseline value |
2 issues | Urine output <0.5 ml/kg/h > 12 h |
Injury: sCr elevated > 2 times or GFR decline > 50% |
sCr elevation > 2.0–3.0 times the baseline value | Elevation > 2.0–2.9 times the baseline value |
3 issues | Urine output <0.3 ml/kg/h > 24 h or no urine for >12 h |
Failure: sCr elevated > 3 times or GFR decline > 75% sCr ≥ 354 μmol/L or an acute increase of ≥ 44 μmol/L Loss: persistent renal failure > 4 weeks ESRD: persistent renal failure > 3 months |
sCr elevation > 3.0 times the baseline value or sCr value ≥ 354 μmol/L or an increase in acute sCr values ≥ 44 μmol/L |
sCr elevated ≥353.6 μmol/L (4 mg/dl) or elevated > 3.0 times the baseline value or starting kidney replacement therapy or <18-year-old patients with a decrease in eGFR to <35 ml/min/1.73 m2 |